MAZE logo

Maze Therapeutics, Inc. (MAZE) EBIT

Annual EBIT:

$57.59M+$156.14M(+158.43%)
December 31, 2024

Summary

  • As of today, MAZE annual earnings before interest & taxes is $57.59 million, with the most recent change of +$156.14 million (+158.43%) on December 31, 2024.
  • During the last 3 years, MAZE annual EBIT has risen by +$168.61 million (+151.87%).
  • MAZE annual EBIT is now at all-time high.

Performance

MAZE EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

Quarterly EBIT:

$0.00+$36.47M(+100.00%)
September 30, 2025

Summary

  • As of today, MAZE quarterly earnings before interest & taxes is $0.00, with the most recent change of +$36.47 million (+100.00%) on September 30, 2025.
  • Over the past year, MAZE quarterly EBIT has increased by +$24.23 million (+100.00%).

Performance

MAZE Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

TTM EBIT:

-$101.60M+$24.23M(+19.26%)
September 30, 2025

Summary

  • As of today, MAZE TTM earnings before interest & taxes is -$101.60 million, with the most recent change of +$24.23 million (+19.26%) on September 30, 2025.
  • Over the past year, MAZE TTM EBIT has dropped by -$26.31 million (-34.94%).
  • MAZE TTM EBIT is now -302.73% below its all-time high of -$25.23 million, reached on September 1, 2023.

Performance

MAZE TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

MAZE EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+158.4%+100.0%-34.9%
3Y3 Years+151.9%+100.0%-302.7%
5Y5 Years+151.9%+100.0%-302.7%

MAZE EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+151.9%at high+100.0%-302.7%+19.3%
5Y5-Yearat high+151.9%at high+100.0%-302.7%+19.3%
All-TimeAll-Timeat high+151.9%at high+100.0%-302.7%+19.3%

MAZE EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(+100.0%)
-$101.60M(+19.3%)
Jun 2025
-
-$36.47M(-3.0%)
-$125.83M(-40.8%)
Mar 2025
-
-$35.40M(-19.1%)
-$89.36M(-9.0%)
Dec 2024
$57.59M
-$29.73M(-22.7%)
-$81.97M(-8.9%)
DateAnnualQuarterlyTTM
Sep 2024
-
-$24.23M(+13.5%)
-$75.29M(+1.3%)
Mar 2024
-
-$28.01M(-21.5%)
-$76.29M(-58.0%)
Dec 2023
-$98.55M(+11.2%)
-$23.05M(+8.6%)
-$48.28M(-91.4%)
Sep 2023
-
-$25.23M
-$25.23M
Dec 2022
-$111.03M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual EBIT year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is Maze Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM EBIT year-on-year change?

What is Maze Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of MAZE is $57.59M

What is the all-time high annual EBIT for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual earnings before interest & taxes is $57.59M

What is Maze Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, MAZE annual earnings before interest & taxes has changed by +$156.14M (+158.43%)

What is Maze Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of MAZE is $0.00

What is the all-time high quarterly EBIT for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $0.00

What is Maze Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, MAZE quarterly earnings before interest & taxes has changed by +$24.23M (+100.00%)

What is Maze Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of MAZE is -$101.60M

What is the all-time high TTM EBIT for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$25.23M

What is Maze Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, MAZE TTM earnings before interest & taxes has changed by -$26.31M (-34.94%)
On this page